These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 21770405

  • 1. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z, Niu J, Xiao Y, Ping Q, Sun M, Huang A, You W, Sang X, Yuan D.
    Mol Pharm; 2011 Oct 03; 8(5):1641-51. PubMed ID: 21770405
    [Abstract] [Full Text] [Related]

  • 2. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
    Su Z, Shi Y, Xiao Y, Sun M, Ping Q, Zong L, Li S, Niu J, Huang A, You W, Chen Y, Chen X, Fei J, Tian J.
    Int J Pharm; 2013 Apr 15; 447(1-2):281-92. PubMed ID: 23396258
    [Abstract] [Full Text] [Related]

  • 3. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X, Gan Y, Gan L, Nie S, Pan W.
    J Pharm Pharmacol; 2008 Aug 15; 60(8):1077-87. PubMed ID: 18644200
    [Abstract] [Full Text] [Related]

  • 4. Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery.
    Niu J, Su Z, Xiao Y, Huang A, Li H, Bao X, Li S, Chen Y, Sun M, Ping Q.
    Eur J Pharm Sci; 2012 Jan 23; 45(1-2):216-26. PubMed ID: 22119655
    [Abstract] [Full Text] [Related]

  • 5. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
    Liu X, Zhang Z, Jiang Y, Hu Y, Wang Z, Liu J, Feng R, Zhang J, Huang G.
    Drug Deliv; 2015 Feb 23; 22(2):223-9. PubMed ID: 24559497
    [Abstract] [Full Text] [Related]

  • 6. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
    Zhang XX, Gan Y, Yang XG, Zhu CL, Gan L, Nie SF, Pan WS.
    Yao Xue Xue Bao; 2008 Jan 23; 43(1):91-6. PubMed ID: 18357740
    [Abstract] [Full Text] [Related]

  • 7. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R, Li YZ, Chen C, Cao YN, Yu MM, Xu L, He B, Jie X, Shen WW, Wang YN, van Dongen MA, Liu GQ, Banaszak Holl MM, Zhang Q, Ke X.
    J Control Release; 2015 Jul 28; 210():160-8. PubMed ID: 26003044
    [Abstract] [Full Text] [Related]

  • 8. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
    Zhang S, Wang J, Pan J.
    Drug Deliv; 2016 Nov 28; 23(9):3696-3703. PubMed ID: 27749105
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
    Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D, Tian X, Liu Y, Zhang Q.
    Int J Biol Macromol; 2012 Apr 01; 50(3):523-9. PubMed ID: 22301003
    [Abstract] [Full Text] [Related]

  • 10. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
    Safwat S, Ishak RAH, Hathout RM, Mortada ND.
    Drug Dev Ind Pharm; 2017 Jul 01; 43(7):1112-1125. PubMed ID: 28276784
    [Abstract] [Full Text] [Related]

  • 11. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
    Luan J, Yang X, Chu L, Xi Y, Zhai G.
    J Colloid Interface Sci; 2014 Aug 15; 428():49-56. PubMed ID: 24910034
    [Abstract] [Full Text] [Related]

  • 12. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.
    Kim CH, Sa CK, Goh MS, Lee ES, Kang TH, Yoon HY, Battogtokh G, Ko YT, Choi YW.
    Int J Nanomedicine; 2018 Aug 15; 13():6661-6675. PubMed ID: 30425481
    [Abstract] [Full Text] [Related]

  • 13. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S.
    Chem Pharm Bull (Tokyo); 2008 Dec 15; 56(12):1645-50. PubMed ID: 19043233
    [Abstract] [Full Text] [Related]

  • 14. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
    Niu J, Huang A, Xiao Y, Su Z, Li H, Ping Q, Bao X, Li S, Chen Y, Sun M.
    J Drug Target; 2013 May 15; 21(5):415-26. PubMed ID: 23597028
    [Abstract] [Full Text] [Related]

  • 15. Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo.
    Li H, Yuan D, Sun M, Ping Q.
    Drug Deliv; 2016 Nov 15; 23(9):3562-3572. PubMed ID: 27432585
    [Abstract] [Full Text] [Related]

  • 16. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G, Liu F, Jia E, Jia L, Zhang Y.
    Drug Deliv; 2016 May 15; 23(4):1393-7. PubMed ID: 26165422
    [Abstract] [Full Text] [Related]

  • 17. Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo.
    Wang H, Sun M, Li D, Yang X, Han C, Pan W.
    Artif Cells Nanomed Biotechnol; 2018 Mar 15; 46(2):313-322. PubMed ID: 28362124
    [Abstract] [Full Text] [Related]

  • 18. [9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].
    Li JC, Sha XY, Zhang LJ, Fang XL.
    Yao Xue Xue Bao; 2005 Nov 15; 40(11):970-5. PubMed ID: 16499078
    [Abstract] [Full Text] [Related]

  • 19. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H, Chen M, Su Z, Sun M, Ping Q.
    Int J Pharm; 2016 Sep 10; 511(1):524-537. PubMed ID: 27452421
    [Abstract] [Full Text] [Related]

  • 20. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P, Geng T, Mahanty A, Li T, Zong L, Wang B.
    Int J Pharm; 2019 Feb 25; 557():374-389. PubMed ID: 30610896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.